These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35755045)

  • 1. Network Pharmacology-Based Investigation of the Molecular Mechanisms of the Chinese Herbal Formula Shenyi in the Treatment of Diabetic Nephropathy.
    Chen K; Deng Y; Shang S; Li P; Liu L; Chen X
    Front Med (Lausanne); 2022; 9():898624. PubMed ID: 35755045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and In Vitro Experiments.
    Han Y; Wei S; Liu C; Nie Y; Yuan S; Ma Y; Zhao Y; Zhang G
    Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37861047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanisms underlying the therapeutic effect of the drug pair Rhubarb-Coptis in diabetic nephropathy using network pharmacology and molecular docking analysis.
    Wu C; Cao L; Liu M; Zhang W; Chen H; Wang R; Liu C; He Z
    Ann Transl Med; 2022 Dec; 10(24):1343. PubMed ID: 36660658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.
    Li Y; Wang L; Xu B; Zhao L; Li L; Xu K; Tang A; Zhou S; Song L; Zhang X; Zhan H
    J Diabetes Res; 2021; 2021():8891093. PubMed ID: 33628839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
    Fu S; Zhou Y; Hu C; Xu Z; Hou J
    BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
    Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
    Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
    Guo MF; Dai YJ; Gao JR; Chen PJ
    J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy.
    Ding S; Wang W; Song X; Ma H
    Evid Based Complement Alternat Med; 2021; 2021():9928282. PubMed ID: 34035828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
    Lin Y; Shen C; Wang F; Fang Z; Shen G
    J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
    Dong Y; Zhao Q; Wang Y
    Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
    Gao F; Zhou Y; Yu B; Xie H; Shi Y; Zhang X; Liu H
    Heliyon; 2024 Jan; 10(1):e23535. PubMed ID: 38223704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
    Wu Z; Ji X; Shan C; Song J; Zhao J
    Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments.
    Fan L; Guo Y; Wu Q; Hu T; Chen X; Guo J; Liu Y; Lu Y; Lin M
    Evid Based Complement Alternat Med; 2023; 2023():6931644. PubMed ID: 36865745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology-Based Investigation on the Mechanism of the JinGuanLan Formula in Treating Acne Vulgaris.
    Gholais NS; Shi C; Zhang J; Liao B; Albarmaqi RA; Tang X; Mi L
    Evid Based Complement Alternat Med; 2022; 2022():6944792. PubMed ID: 35873639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.